These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Selection and identification of DNA aptamers against DC-SIGN].
    Author: Chen F, Zeng J, Sun P, Pan Q, Zhang XL.
    Journal: Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1133-6. PubMed ID: 19068192.
    Abstract:
    AIM: To develop the high affinity DNA aptamers which can selectively recognize DC-SIGN protein as putative preventive reagents and drugs against infectious diseases. METHODS: A technique of cell surface-SELEX (TECS-SELEX) was employed to screen the DNA aptamers recognizing DC-SIGN displayed on the surface of NIH3T3 cells. Some aptamers from the aptamer pools with the highest affinity were cloned. The binding affinities between the aptamers and target cells were measured by flow cytometry and ELISA. The values of IC(50); were determined to detect the toxicity of aptamers for cells by MTT method. RESULTS: The 14th aptamer pool had the highest affinity and the binding rates between single aptamer (ZD8) and DC-SIGN protein were in a dose dependent manner. DC-SIGN antibody can competitively inhibit the binding reactions between the aptamers and their target cells. The selected aptamers have very low or no toxicity for hepatic cells. CONCLUSION: The selected DNA aptamers bound to DC-SIGN protein with high affinity and specificity have been successfully selected, and they can be used both as preventive reagents and drugs against infectious diseases, such as AIDS, hepatitis C and tuberculosis.
    [Abstract] [Full Text] [Related] [New Search]